Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Egyptian Company for Pharmaceutical & Chemical Industries (EPCI) is a prominent pharmaceutical manufacturer based in Egypt and a key subsidiary of the state-owned Holding Company for Pharmaceuticals (HoldiPharma). The company specializes in the production of a diverse range of generic medicines, including human and veterinary pharmaceuticals, across various dosage forms such as tablets, capsules, and injectables. EPCI's product portfolio addresses several major therapeutic areas, including anti-infectives, cardiovascular health, gastrointestinal disorders, and respiratory diseases. Operating with modern facilities that adhere to international Good Manufacturing Practice (GMP) standards, the company serves the Egyptian domestic market and exports to regional markets in the Middle East and Africa. EPCI plays a crucial role in the Egyptian healthcare sector by ensuring the availability of high-quality, affordable essential medicines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Egyptian Company for Pharmaceuticals.